Advanced CML

1 clinical trials · Condition

Record	Firm	Date
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia (NCT02795520)	OncoTherapy Science, Inc.	2016-04-01

Every clearance here is in the API, with alerts when new ones post.